VKTX earnings date and last-quarter result: next report 2026-07-29, last quarter miss, P/E -9.01. Updated 2026-07-23.
Viking Therapeutics (VKTX) Research Hub
Viking Therapeutics (VKTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 24.21 USD (-0.78%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.01, market cap 4.30B. This hub links to the full technical, earnings and options research available for VKTX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 24.21 USD (-0.78%) |
| 52-week range | 24.01 USD – 43.1 USD |
| Trend regime | Range |
| 14-day RSI | 34.2 (Bearish) |
| Trailing P/E | -9.01 |
| Market cap | 4.30B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for VKTX
Covered Call on VKTX: how it works, illustrative setup around the real 24.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VKTX: how it works, illustrative setup around the real 24.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VKTX: how it works, illustrative setup around the real 24.21 USD price, max profit/loss, breakeven and when to use it. Educational.
VKTX technical analysis: range, last 24.21 USD, RSI 34.2, 52w range 24.01 USD–43.1 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VKTX in?
Viking Therapeutics (VKTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VKTX in an uptrend or downtrend?
As of 2026-10-26, VKTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VKTX's trailing P/E ratio?
VKTX's trailing P/E is -9.01, with a market cap of 4.30B. See the earnings research page for full valuation detail.
When does VKTX next report earnings?
VKTX is next scheduled to report earnings on 2026-07-29.